Wyndham Hotels & Resorts announced a quarterly cash dividend of $0.43 per share, payable on December 30, 2026, to shareholders of record as of December 15, 2026. As one of the world's largest hotel franchising companies, Wyndham operates about 8,500 hotels globally and serves millions of loyalty program members. This dividend reflects the company's ongoing commitment to returning value to shareholders amid various economic and industry risks. Investors should monitor Wyndham's official channels for updates and disclosures.
Wyndham Hotels & Resorts declared a quarterly cash dividend of $0.43 per share, payable on December 30, 2026. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Nov 13, 2026 04:12 WIB: out of 134 priced US stocks, 22 rose and 112 fell. Notable movers include Quantumscape Corp (QS) at USD 3.89 with a 1-day change of -7.60%, Alibaba Group (BABA) at USD 94.49 down 6.92%, and Aterian Inc (ATER) at USD 0.86 down 6.62%.
Super League Enterprise, a company specializing in audience intelligence and media activation for the gaming industry, announced it will release its financial results for the third quarter ending September 30, 2026, on November 16, 2026, after market...
Stantec Inc. reported a 9.4% increase in net revenue to $1.9 billion for Q3 2026, driven by organic and acquisition growth. Adjusted EBITDA rose 16.6% to $377.1 million with a record margin of 20.2%, while adjusted EPS grew 23.5% to $1.89. The compan...
Siemens reported earnings per share of $1.62 and revenue of $26.28 billion, both exceeding analyst expectations. The company saw record orders and double-digit revenue growth in its smart infrastructure and digital industries units, prompting it to r...
ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...
The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...
